Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer

High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer

Targeting STAT3 enhances NDV-induced immunogenic cell death in prostate cancer cells

Substantial tumor regression in prostate cancer patient with extensive skeletal metastases upon Immunotherapy (APCEDEN): A case report

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

Substantial remission of prostate adenocarcinoma with dendritic cell therapy APCEDEN in combination with chemotherapy

Past, Current, and Future of Immunotherapies for Prostate Cancer

Capacitive hyperthermia as an alternative to brachytherapy in DNA damages of human prostate cancer cell line (DU-145)

Potentiating prostate cancer immunotherapy with oncolytic viruses

Myeloid and plasmacytoid dendritic cell vaccinations for castration-resistant prostate cancer patients.